UB Holds First Clinical and Translational Research Colloquium

Published October 25, 2011 This content is archived.

The UB Clinical and Translational Science Institute’s first annual colloquium highlighted studies and novel technologies designed at UB and Roswell Park Comprehensive Cancer Center to speed the time it takes new medical tests and treatments to go from the laboratory to patients.

Investigators who presented their research at the colloquium have won pilot study grants from the UB CTRC.

Area scientists, researchers and clinicians attended the Oct. 21 event at the Roswell Park Center for Genetics and Pharmacology.

Interdisclipinary Projects, External Funding Potential

Investigators who presented their research at the colloquium had won pilot study grants from the UB CTRC.

Their projects were selected because they involve interdisciplinary collaboration and were determined to have greatest potential to receive external funding, explains Timothy F. Murphy, MD, senior associate dean for clinical and translational research and SUNY Distinguished Professor of Medicine.

Awardees and Their Translational Research Projects

Awardees and the research studies they presented at the colloquium are as follows:

Moray Campbell
Department of Pharmacology and Therapeutics
Roswell Park Comprehensive Cancer Center

Olagnostic and prognostic potential of serum mRNA expression in prostate cancer, which studies the use of microRNA as a biomarker for characterizing prostate cancer

Wen Wee Ma
Department of Medicine
Roswell Park Comprehensive Cancer Center

System pharmacological analysis of molecularly target agents in pancreatic cancer: pharmacodynamic design of novel therapeutic trials to develop a new predictive pharmacologic model to better understand drug-cancer-patient interactions in pancreatic cancer

Nicholas Norgard
UB Department of Pharmacy Practice

Use of niacin to overcome aspirin resistance, to study niacin’s use in people with low HDL cholesterol

Jun Qu
UB Department of Pharmaceutical Sciences

Proteomic analysis of laser microdissected biopsy samples: transforming individualized therapy of prostate cancer, to identify potential disease/therapy markers in prostate cancer tissues from biopsy samples

Rutao Yao
Department of Nuclear Medicine

Development of a small animal single photon emission computed tomography and computed tomography dual functional imager with an X-ray detector, to develop better ways to do non-invasive, in vivo animal imaging

Grant Program Demonstrates Commitment to Research


The following entities allocated a total of $200,000 to support the pilot study grants:

  • dean’s offices of UB’s five health sciences schools (medicine, dental medicine, nursing, pharmacy and pharmaceutical sciences, and public health and health professions)
  • UB Office of the Vice President for Research
  • UB Office of the Vice President for Health Sciences
  • Roswell Park Comprehensive Cancer Center

The second round of funding, which will also total $200,000, is currently open.

“This support, especially in these tight financial times, demonstrates a powerful commitment on behalf of clinical and translational science here in Buffalo,” says Murphy.


Fliesler and Epstein Direct the Award Programs

Steven J. Fliesler, PhD, directs the award program for Novel Clinical and Translational Methodologies. He is the Meyer H. Riwchun Endowed Chair Professor, vice chair and director of research in the Department of Ophthalmology and Ira G. Ross Eye Institute Vision Research Center. Fliesler is also a research health scientist at the Buffalo VA Medical Center.

The award program for Pilot and Collaborative Translational and Clinical Studies is directed by Leonard H. Epstein, PhD, SUNY Distinguished Professor of pediatrics.